Clinical Trials Browser

Adenocarcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Melanoma, Mouth Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma

NCT07451340 2026-03-31

Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women

Recruiting

215 enrolled

Gynecologic

Healthy

NCT05142033 2026-03-27

ASAP

Recruiting

25,000 enrolled

BreastCNSGastrointestinalGynecologicOther hematologic neoplasmThoracic

Breast Neoplasms, Colonic Neoplasms, Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Central Nervous System Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT06447064 2026-03-25

(CLOCS-2)

Recruiting

2,900 enrolled

GastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT07493928 2026-03-25

HART

Recruiting

120 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07125209 2026-03-24

Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer

Recruiting

18 enrolled

Gynecologic

Ovarian Neoplasms

NCT06418243 2026-03-23

3D-PEDSURG

Recruiting

60 enrolled

Gynecologic

Neoplasms, Pelvic Neoplasms

NCT07167433 2026-03-19

OLIVIA

Recruiting

250 enrolled

Gynecologic

Ovarian Neoplasms

NCT07469709 2026-03-13

PRO-ACTIVE

Recruiting

850 enrolled

BreastDermatologicGastrointestinalGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Melanoma, Ovarian Neoplasms

NCT06349642 2026-03-12

ELEPHAS-04

Recruiting

324 enrolled

DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Clear-cell metastatic renal cell carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT05977621 2026-03-06

(TRUS)

Recruiting

17 enrolled

Gynecologic

Uterine Neoplasms

NCT04723095 2026-03-05

NeCTuR

Recruiting

750 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07451483 2026-03-05

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

Recruiting

500 enrolled

GastrointestinalGynecologic

Hernia, Ventral, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

Recruiting

20 enrolled

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms

NCT06935344 2026-03-03

PROVE

Recruiting

1,300 enrolled

Gynecologic

Genetic Risk Score, Ovarian Neoplasms

NCT06995833 2026-03-02

Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance

Recruiting

50 enrolled

Gynecologic

Endometrial Neoplasms

NCT07433660 2026-03-02

THRIVE

Recruiting

1,000 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms

NCT07435623 2026-03-02

Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study

Recruiting

300 enrolled

Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT04830709 2026-02-27

SCOUT-1

Recruiting

750 enrolled

Gynecologic

Ovarian Neoplasms

NCT05574673 2026-02-27

HERO

Recruiting

1,000 enrolled

Gynecologic

Kenny-Caffey syndrome, Type 1, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07382583 2026-02-25

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer

Recruiting

270 enrolled

Gynecologic

Endometrial Neoplasms

NCT07041606 2026-02-24

IREN

Recruiting

500 enrolled

Gynecologic

Endometrial Neoplasms

NCT05974150 2026-02-23

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Recruiting

25 enrolled

BreastGynecologicOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Lung Neoplasms, Multiple Myeloma, Ovarian Neoplasms, Leukemia, Myeloid, Acute

NCT06572735 2026-02-23

PARIB-OLD-PRO²

Recruiting

50 enrolled

Gynecologic

Neoplasms, Ovarian Neoplasms

NCT05102240 2026-02-20

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

Recruiting

1,800 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05046080 2026-02-19

Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix

Recruiting

70 enrolled

Gynecologic

Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type

NCT06689956 2026-02-19

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study

Recruiting

212 enrolled

Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

NCT06890273 2026-02-18

DUOLife

Recruiting

150 enrolled

Gynecologic

Endometrial Neoplasms

NCT07400809 2026-02-17

Retro-COSMOS

Recruiting

350 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis, Patient Compliance, Recurrence

NCT07407959 2026-02-17

Screening and Staging of Benign vs Malignant Pelvic Abnormalities

Recruiting

60 enrolled

GenitourinaryGynecologic

Prostatic Neoplasms, Endometrial Neoplasms

NCT00488878 2026-02-13

Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

Recruiting

2,000 enrolled

Gynecologic

Ovarian Neoplasms

NCT03862677 2026-02-13

IMPrOVE

Recruiting

300 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT04981119 2026-02-13

BASECAMP-1

Recruiting

200 enrolled

BreastGastrointestinalGenitourinaryGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT05774561 2026-02-12

Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

Recruiting

480 enrolled

GynecologicHead & Neck

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

NCT07214584 2026-02-12

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

Recruiting

55 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT07397624 2026-02-12

ESG-ENDO

Recruiting

74 enrolled

Gynecologic

Endometrial Neoplasms

Clinical Trials

DETECTR

The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support

A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

PROBE-II

IGNITE-V

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

The Registry of Genetic Alterations of Taiwan Ovarian Cancer

PROACTION:

SENTRY

HPV-Vac-S

Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

DP-04

Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women

ASAP

(CLOCS-2)

HART

Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer

3D-PEDSURG

OLIVIA

PRO-ACTIVE

ELEPHAS-04

(TRUS)

NeCTuR

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

Detecting HPV DNA in Anal and Cervical Cancers

PROVE

Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance

THRIVE

Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study

SCOUT-1

HERO

Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer

IREN

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

PARIB-OLD-PRO²

Development of Clinically High Efficient Platforms for Individualised Treatment of Cervix Cancer

Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study

DUOLife

Retro-COSMOS

Screening and Staging of Benign vs Malignant Pelvic Abnormalities

Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors

IMPrOVE

BASECAMP-1

Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy

ESG-ENDO